SBIR/STTR Research Award

Durable Emitters for Nanospray Mass Spectrometry

Award identifier 513159492c91d12a7fa422cd823a4396e53b8d2939a1788e8f56d3212ad5cb54Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$135,715

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOGENESYS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION: (provided by applicant) The long-term goal of this project is to develop miniaturized electrospray (or nanospray) emitters that have enhanced durability versus those which are currently available. While nanospray mass spectrometry has improved detection limits, requires less sample volume, and much lower flow rates (resulting in much reduced consumption of analyte), current emitters using gold coatings are highly suspectible to destruction by electrical discharge. Here, we pursue conductive polymer coatings which exhibit high resistance to electrical discharge as alternative coatings for nanospray mass spectrometry. The development of such durable emitters will permit the stable coupling of capillary separations techniques directly to nanospray mass spectrometry for high sensitive detection and characterization of biological molecules directly from complex mixtures of biomolecules in biological fluids (e.g., cerebrospinal fluid, blood plasma, tear fluid, etc.). Such a powerful combination of analytical technologies will have important implications in detecting biomolecules which are indicative of disease states (for example protein isoforms of hemoglobin or prealbumin) as well as providing information on in vivo drug pharmacokinetics by measuring pharmaceutical products to extremely low levels directly from biological fluids (e.g. metabolism of anti-cancer drugs and their metabolic products directly from blood plasma). PROPOSED COMMERCIAL APPLICATION: The development of conductive polymer coated nanospray emitters will provide for the first time a durable nanospray emitter capable of functioning throughout the course of a capillary separations technique coupled directly to nanospray. Thus, analysis of subpicomole levels of biological molecules directly from biological fluids will be possible, with application to biomedicine and pharmaceutical science.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.